Navigation Links
Risk of common vaginal infection linked to preterm birth appears higher for blacks
Date:8/13/2007

BOSTON, Aug. 11 Risk of a common vaginal infection linked to preterm birth appears to escalate when even one partner is African-American, according to a University of Pittsburgh School of Medicine study presented today at the 34th annual meeting of the Infectious Diseases Society for Obstetrics and Gynecology in Boston.

When a pregnant woman has bacterial vaginosis, her risk of preterm birth goes up, said Hyagriv Simhan, M.D., M.S.C.R., assistant professor of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh School of Medicine. And now we can say that gauging risk for bacterial vaginosis is not as simple as just looking at the woman. We also should consider her partner.

Bacterial vaginosis (BV) is a common gynecological infection that affects up to 50 percent of women in some populations. BV is characterized by an increase in vaginal alkalinity and an overgrowth of abnormal bacteria. Among the infections more prominent symptoms is a milky, foul-smelling discharge.

For years, clinicians have thought of BV infection as a minor problem, but in addition to increasing the risk for preterm birth, other studies have shown that women who have BV also are more likely to get herpes and other sexually transmitted diseases, including HIV, said Dr. Simhan, a maternal-fetal medicine specialist at the Magee-Womens Hospital of the University of Pittsburgh Medical Center.

For this observational study, Dr. Simhan and his colleagues considered 325 women who were in their first trimester of pregnancy. Among these women, 129 (39.7 percent) were white female/white male partnerships, 35 (10.8 percent) were white female/black male couples, 12 (3.7 percent) were black female/white male couples, and 149 (45.9 percent) were black female/black male partnerships.

Generally, BV was less common among white women compared to black women in the group. But notably, partner race also showed an influence on BV risk, D
'/>"/>

Contact: Michele D. Baum
BaumMD@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
2. Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine
3. U-M scientists find genes that control growth of common skin cancer
4. Harmful Bacterium Commonly Found in Poultry May Survive Refrigeration and Frozen Storage Combined
5. Iron exporter revealed that may explain common human disorder
6. Does vitamin C help prevent or treat the common cold? Maybe not, after all.
7. High-powered gene profiles provide clues to genes involved in common form of lung cancer
8. Men Estimate Mens Risks Of Common Disorders Higher Than Women Do, And Vice Versa
9. Doctors should stop prescribing antibiotics for the common cold, review advises
10. Drug resistant avian influenza viruses more common in Southeast Asia than North America
11. Most common lung cancers may begin in newly discovered cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...in harmony with their arboreal hosts. But new rese...heir trees of choice, the ants can get destructive... in the November issue of the American Naturalist...ve trees, and it reopens a centuries-old debate on...s and certain species of plants and trees have coz...
(Date:11/5/2009)...rded a training grant in the amount of $2,756,719 ...rative Graduation Education and Research Training ...be awarded to Kent State. The grant, which is fund...t of 2009, runs through 2014. , The grant funds ...ic resource sensing (EARS). The purpose of the pro...
(Date:11/4/2009)... turns out, hold the power to help militaries and ...ean up toxic waste on test sites. , Compounds kn... back in World War II and have been used in milita...unds are often used to propel tank shells and act ...h increased knowledge of their environmentally har...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2MedCath Names Art Parker Executive Vice President and Chief Financial Officer 58084 1MedCath Names Art Parker Executive Vice President and Chief Financial Officer 58084 2Anthem Blue Cross and Blue Shield Awarded NCQAs Accreditation Status of Excellent 58081 1Anthem Blue Cross and Blue Shield Awarded NCQAs Accreditation Status of Excellent 58081 2One Health Commission Teaming Up With World Rabies Day to Spread the One Health Message 58078 1One Health Commission Teaming Up With World Rabies Day to Spread the One Health Message 58078 2
..., Belgium The changes in our climate, producing e... enormous impact on our crops − to put it br...now concluded a research agreement with Bayer BioS...ter of Bayer CropScience, to look into this proble... to elucidate the mechanisms that indicate how pla...
...m, a rocky mineral is abundant in desert regions w...ut oil and gas fields are common. Writing in Inte... Peter van der Gaag of the Holland Innovation Team...ea of using the untapped energy from oil and gas f... Fresh water resources are scarce and will be more...
...N, Va., June 10 Stanley, Inc. (NYSE:,SXE), a lead...al services,to the U.S. federal government, announ...reement to acquire Oberon Associates, Inc. (Oberon...ormation technology services,company. The purchase...subject to certain working capital and other adjus...
Other Biology News:VIB and Bayer join forces for plant research 2VIB and Bayer join forces for plant research 3Rocky water source 2Stanley to Acquire Oberon Associates 2Stanley to Acquire Oberon Associates 3Stanley to Acquire Oberon Associates 4
(Date:11/5/2009)... Call on Thursday, November 5, 2009 at 4:30 p.m. E...5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceutica...OGXI ) today reported unaudited financial results ...ber 30, 2009 and reviewed the Company,s highlights...g consolidated results reflect the operations of O...
(Date:11/5/2009)...N.Y., Nov. 5 BioSpecific...ceutical company developing first-in-class collage... results for the third quarter ended September 30,...ptember of this year, the FDA,s Arthritis Advisory...2-0, the approval of XIAFLEX(TM) for the treatment...
(Date:11/5/2009)..., Texas, Nov. 5 Wound Ma...ay that it has entered into a Letter of Intent to ...Health Technologies, Inc. (OTC Bulletin Board: VHG...00 in cash and debt, 4,000,000 shares of WNDM and ... on the Veriscrip technology being acquired from V...
(Date:11/5/2009)...alif., Nov. 5 WaferGen B...ing developer of state-of-the-art genetic analysis...Ph.D. has joined the company,s Scientific Advisory...and commercializing novel molecular diagnostics fo...the development of computational biology systems f...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
...timicrobial sets the new global standard to er...and lethal,microorganisms commonly found in health... C. difficile, NEWARK, N.J., Aug. ... Ygiene(TM) Hospital Grade antimicrobial against,a... of microorganisms which,represent the major sourc...
...First Diagnostic Test Based on Company,s, microR...dical Center, Approved for C...dite Commercialization of its ... Three Additional microRNA-based Cancer Tests in ... Israel and JERSEY CITY, New Jersey, August 19, Ro...
...NUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS )...ts full year 2008 guidance. The Company has record...nses and certain balance sheet accounts,to record ...ation that were,not appropriately recorded in prio...cial Accounting Standard ("SFAS") No. 123R on Janu...
Other Biology Technology:BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World 2BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World 3BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World 4Rosetta Genomics Reports Second Quarter 2008 Financial Results 2Rosetta Genomics Reports Second Quarter 2008 Financial Results 3Rosetta Genomics Reports Second Quarter 2008 Financial Results 4Rosetta Genomics Reports Second Quarter 2008 Financial Results 5Rosetta Genomics Reports Second Quarter 2008 Financial Results 6Rosetta Genomics Reports Second Quarter 2008 Financial Results 7Rosetta Genomics Reports Second Quarter 2008 Financial Results 8Rosetta Genomics Reports Second Quarter 2008 Financial Results 9Rosetta Genomics Reports Second Quarter 2008 Financial Results 10Rosetta Genomics Reports Second Quarter 2008 Financial Results 11Rosetta Genomics Reports Second Quarter 2008 Financial Results 12VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 2VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 3VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 4
Invitrogen Magnetic Stand from Invitrogen
H2A.X Phosphorylation Assay Kit (Flow Cytometry) from Upstate
H2A.X Phosphorylation Assay Kit (Chemiluminescence Detection) from Upstate
...fusion system. For real-time or pre-programmed liq..., electrochemistry, or general liquid-handling res...with 10 millisecond accuracy Run experiments auto...for accuracy and flexibility Turnkey perfusion sy...
Biology Products: